Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib with Second-line Chemotherapy in Metastatic Colorectal Cancer
NCT03412994Phase 2Unknown
- Start
- Feb 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Rivoceranib in colorectal cancer (metastatic) (mCRC). Status: unknown.
02
Drugs
Rivoceranib
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT03412994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03412994.